ID   IOSE19CMYC.BRAF
AC   CVCL_YZ59
SY   IOE19CMYC.BRAF
DR   Wikidata; Q98126782
RX   PubMed=21859834;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1097; BRAF (Note=With p.Val600Glu).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ55 ! IOSE19CMYC
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
RX   PubMed=21859834; DOI=10.1093/carcin/bgr140;
RA   Lawrenson, Kate
RA   Sproul, Duncan
RA   Grun, Barbara
RA   Notaridou, Maria
RA   Benjamin, Elizabeth
RA   Jacobs, Ian J.
RA   Dafou, Dimitra
RA   Sims, Andrew H.
RA   Gayther, Simon Andrew
RT   "Modelling genetic and clinical heterogeneity in epithelial ovarian
RT   cancers.";
RL   Carcinogenesis 32:1540-1549(2011).
//